Anna Betiuk-Pedzinska
Mickiewicz Str. 2A
Bialystok, PD 15222, Poland
Bialystok, PD 15222, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Chronic simultaneous inducible nitric oxide synthase (iNOS) and peripheral cannabinoid CB1 receptors blockade ameliorates pulmonary hypertension in monocrotaline-induced rat model.
Journal: Frontiers in pharmacology
Published: March 16, 2026
Initial Body Weight as an Important Factor for Improving the Reliability and Translational Relevance of the Preclinical Monocrotaline-Induced Rat Pulmonary Hypertension Model.
Journal: International journal of molecular sciences
Published: August 14, 2025
Comparison of Cardioprotective Potential of Cannabidiol and β-Adrenergic Stimulation Against Hypoxia/Reoxygenation Injury in Rat Atria and Ventricular Papillary Muscles.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: September 26, 2024
Re-evaluation of the cardioprotective effects of cannabinoids against ischemia-reperfusion injury according to the IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria.
Journal: Frontiers in pharmacology
Published: February 06, 2024
Evaluation of the Expression and Localization of the Multifunctional Protein CacyBP/SIP and Elements of the MAPK Signaling Pathway in the Adrenal Glands of Rats with Primary and Secondary Hypertension.
Journal: International journal of molecular sciences
Published: November 15, 2023
Cannabidiol treatment changes myocardial lipid profile in spontaneously hypertensive rats.
Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD
Published: February 28, 2023
Effects of the peripheral CB1 receptor antagonist JD5037 in mono- and polytherapy with the AMPK activator metformin in a monocrotaline-induced rat model of pulmonary hypertension.
Journal: Frontiers in pharmacology
Published: June 09, 2022
The potential of cannabinoids and inhibitors of endocannabinoid degradation in respiratory diseases.
The potential of cannabinoids and inhibitors of endocannabinoid degradation in respiratory diseases.
Journal: European journal of pharmacology
Published: August 03, 2021
Beneficial and harmful effects of CB1 and CB2 receptor antagonists on chronotropic and inotropic effects related to atrial β-adrenoceptor activation in humans and in rats with primary hypertension.
Journal: Clinical and experimental pharmacology & physiology
Published: May 20, 2021
Chronic cannabidiol treatment reduces the carbachol-induced coronary constriction and left ventricular cardiomyocyte width of the isolated hypertensive rat heart.
Journal: Toxicology and applied pharmacology
Published: September 19, 2020
Last Updated: 09/26/2026